Andrew T Thliveris is a Madison, Wisconsin based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Andrew T Thliveris is 39603 for Ophthalmology in Wisconsin. Andrew T Thliveris is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Andrew T Thliveris speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
22 Stone Crest Cir, Madison, Wisconsin, 53717-1320
Phone:
000-000-0000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1023084555
NPI Enumeration Date:
24 Feb, 2006
NPI Last Update On:
26 Sep, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Andrew T Thliveris are as mentioned below.
License Number
Specialization
State
Status
39603
Ophthalmology
Wisconsin
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
22 Stone Crest Cir, Madison, Wisconsin
Zip:
53717-1320
Phone Number:
--
Fax Number:
--
Patients can reach Andrew T Thliveris at 22 Stone Crest Cir, Madison, Wisconsin or can call to book an appointment on 000-000-0000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.